Form 8-K Sagent Pharmaceuticals, For: Nov 04

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. TMUS
9. SPY
10. SBUX

Go back to Form 8-K Sagent Pharmaceuticals, For: Nov 04

Sagent Pharmaceuticals (SGNT) Tops Q3 EPS by 10c; Guides FY14 Revs Below Views

November 4, 2014 9:29 AM EST

Sagent Pharmaceuticals (NASDAQ: SGNT) reported Q3 EPS of $0.06, $0.10 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $65.4 million versus the consensus estimate of $64.01 million.

Sagent Pharmaceuticals sees FY2014 revenue of $275-285 million, versus the consensus of $287.8 million.

For earnings... More